Caron Introduces New Environmental Test Chambers and Refrigerated Incubators - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Caron Introduces New Environmental Test Chambers and Refrigerated Incubators



Caron's new environmentally controlled stability chambers include large-capacity environmental chambers (7000 Series) and refrigerated incubators (7001 Series) in two-door (50 cu. ft.) and three-door (75 cu. ft.) configurations.

The new stability chambers are designed in accordance with FDA ICH Q1A Guidelines and can be used for numerous customer applications, including shelf-life studies, stability and package testing, and temperature-elevation studies. The stability chambers have several new features, including humidity control, self-closing doors with locks, CFC-free foam insulation, and a full-color user interface. These new design features help yield up to 71% in energy savings. The environmental chambers and refrigerated incubators also have a 7” color touchscreen that has easy-to-read icons and a display that can be operated with gloves on. Both products are constructed of stainless steel, making them easy to clean and highly resistant to corrosion.

Source:Caron

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here